Even higher risk seen with concomitant use with opioids or benzodiazepines. HealthDay News — Gabapentinoids are associated with an increased risk for drug poisoning, particularly in the short-term ...
Supported by the phase 3 ALLEGORY trial, the application moves obinutuzumab closer to becoming a new standard for patients with active, autoantibody-positive SLE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results